State research · Northeast

Connecticut R&D Tax Credit

Program status: Active — Two Corporate R&D Credits

Connecticut provides separate research and development and research and experimental expenditure tax credits. The calculation depends on the applicable statute, taxpayer type, Connecticut research expenditures, prior-year expenditures, and tax year.

Connecticut R&D tax credit at a glance

Program Status
Active
Program Type
Multiple R&D Credits
R&D Expenses Credit
1%–6% / 6% for qualified small businesses
Primary Programs
§12-217n and §12-217j
R&E Incremental Credit
20% of the increase
Research Location
Connecticut
Carryforward
Generally 15 years for current credits
Refund / Exchange
Qualified small businesses, subject to requirements
Tax Years
2024, 2025, 2026

Note: Rules verified October 2026 · calculator supports income years 2024–2026 (corporate taxpayers).

Key takeaway

Connecticut Has Two Separate R&D-Related Corporate Credits

Connecticut has two separate R&D-related corporate tax credits. The §12-217n credit is generally based on Connecticut R&D expenses, while the §12-217j credit is an incremental credit based on the increase in Connecticut research and experimental expenditures.

Not 6% + 20%: the §12-217j increment reduces the §12-217n expense base

Connecticut R&D Credit Status

Connecticut has two active corporate research credits — the Research and Development Expenses Tax Credit (§12-217n) and the Research and Experimental Expenditures Tax Credit (§12-217j) — with different calculations, limitations and forms. It does not have a single generic state R&D credit.

The federal R&D tax credit is a separate credit under IRC §41 and is not affected by Connecticut’s state-level status. See how states are classified.

Key Facts

Program
R&D Expenses Tax Credit (§12-217n) and R&E Expenditures Tax Credit (§12-217j)
Credit rate
§12-217n: 6% for qualified small businesses; otherwise 1% up to $50M, $500,000 + 2% over $50M, $1,500,000 + 4% over $100M, $5,500,000 + 6% over $200M. §12-217j: 20% of the increase over the preceding income year.
Calculation method
§12-217n: non-incremental, on R&D expenses reduced by the §12-217j increment; §12-217j: incremental over the preceding income year
Carryforward
§12-217n credits earned in income years beginning on or after January 1, 2021: 15 income years. §12-217j: 15 income years. No carryback.
Refundability
Not generally refundable. Qualified small businesses with no Corporation Business Tax liability may exchange current-year credits for 65% of value (90% for qualifying biotechnology companies, 2025+), up to $1.5 million a year (§12-217ee).
Research location
Research must be conducted in Connecticut
Key statutes
Conn. Gen. Stat. §§12-217n, 12-217j, 12-217ee, 12-217zz
Primary form
CT-1120 RDC (§12-217n); CT-1120RC (§12-217j); CT-1120K; CT-1120 XCH (exchange)
Application
No pre-approval for the credits; Form CT-1120 XCH for an exchange
Caps and limits
R&D/R&E credits up to 70% of tax (2023+); §12-217n current-year limit per CT-1120 RDC Part II; exchange up to $1.5 million a year
Effective
Ongoing; 2025 changes for income years beginning on or after January 1, 2025
Expiration
No general sunset identified
Tax offset
Corporation Business Tax
Tax years researched
2024, 2025, 2026

Connecticut Has Two R&D-Related Credits

These credits are related but are not interchangeable. Connecticut specifically requires taxpayers claiming §12-217j to reduce the R&D expenses otherwise taken into account under §12-217n by the amount of the incremental increase for which the §12-217j credit is given.

Non-incremental

Research and Development Expenses Credit

Rate: 1%–6% schedule; 6% for qualified small businesses

A credit based on qualifying Connecticut research and development expenses — not only the increase.

Carryforward
15 income years (credits earned in income years beginning on or after January 1, 2021)
Tax-liability offset
CT-1120 RDC Part II limit and the 70% R&D/R&E limit
Research location
Connecticut
Statute
Conn. Gen. Stat. §12-217n
Form
CT-1120 RDC

Official source: Conn. Gen. Stat. §12-217n — Research and development expenses credit (official external site, opens in a new tab)

Research and Development Expenses Credit — §12-217n

CT-1120 RDCTax years: 2024–2026Conn. Gen. Stat. §12-217n

The credit applies against the Connecticut Corporation Business Tax for qualifying research and development expenses incurred in Connecticut. Qualifying expenses follow Connecticut's statutory definition: research or experimental expenditures under IRC §174 as in effect on May 28, 1993, and certain basic research payments under IRC §41, subject to Connecticut requirements. The definition is not tied to current federal §174 amortization.

Qualified small business: previous-year gross income not exceeding $100,000,000 (not met through transactions with related persons) — tentative credit = 6% of qualifying Connecticut R&D expenses. This $100 million test is separate from the $70 million test for the credit exchange.

§12-217n rate schedule for other taxpayers
Qualifying R&D expensesTentative credit
$50 million or less1% of expenses
More than $50 million, up to $100 million$500,000 + 2% of the amount over $50 million
More than $100 million, up to $200 million$1,500,000 + 4% of the amount over $100 million
More than $200 million$5,500,000 + 6% of the amount over $200 million

Large Enterprise Zone business: a business employing more than 2,500 people in Connecticut, with annual revenues over $3 billion and headquartered in an Enterprise Zone receives the greater of the normal tentative credit or 3.5% of its qualifying R&D expenses.

Source: Conn. Gen. Stat. §12-217n — Research and development expenses credit (official external site, opens in a new tab) · Research and Development Expenses Tax Credit (Corporation Credit Guide) (official external site, opens in a new tab) · 2025 Form CT-1120 RDC — Research and Development Expenditures Tax Credit (§12-217n) (official external site, opens in a new tab)

Research and Experimental Expenditures Credit — §12-217j

CT-1120RCConn. Gen. Stat. §12-217j
  1. Current-year Connecticut R&E Qualifying research and experimental expenditures for research conducted in Connecticut.
  2. Prior-year Connecticut R&E The preceding income year only — not a three-year average or the federal ASC.
  3. Incremental increase Current year − prior year. If current-year expenditures do not exceed the prior year, the credit is $0.
  4. 20% credit Incremental increase × 20% — not 20% of all R&E expenditures.

Qualifying expenditures are research and development costs in the experimental or laboratory sense and costs incident to the development or improvement of a product, including pilot models, processes, formulas, inventions, techniques, patents or similar property. Only amounts spent directly on research and experimental expenditures in Connecticut count.

Source: Conn. Gen. Stat. §12-217j — Research and experimental expenditures credit (official external site, opens in a new tab) · Research and Experimental Incremental Expenditures Tax Credit (Corporation Credit Guide) (official external site, opens in a new tab) · 2025 Form CT-1120RC — Research and Experimental Expenditures Tax Credit (§12-217j) (official external site, opens in a new tab)

Credit Interaction

A taxpayer claiming §12-217j must reduce the R&D expenses otherwise used for §12-217n by the incremental amount for which the §12-217j credit is given.

Interaction example (qualified small business)
StepAmount
Current-year R&D expenses$10,000,000
Current-year R&E / prior-year R&E$10,000,000 / $8,000,000
Increment$2,000,000
§12-217j credit (20%)$400,000
Adjusted §12-217n base ($10M − $2M)$8,000,000
§12-217n tentative credit (6%)$480,000

Illustrative only. Actual current-year credit utilization may be lower because Connecticut imposes additional credit-use limitations.

Source: Conn. Gen. Stat. §12-217n — Research and development expenses credit (official external site, opens in a new tab)

Credit Limitations

Current-year use

Tentative credit is not cash savings. For §12-217n, Form CT-1120 RDC Part II limits the current-year amount:

CT-1120 RDC Part II
LineComputation
1Allowable tentative credit
2Line 1 × 33⅓%
3Corporation Business Tax after other applicable credits, before the R&D credit
4Line 3 × 50%
5a / 5bLine 1 × 2 / Line 3 × 90%
5Lesser of line 5a or 5b
6Greater of line 4 or line 5
7Lesser of line 2 or line 6

Under §12-217zz, credits generally may not exceed 50.01% of tax, but R&D and R&E credits may be used up to 70% of tax for income years beginning in 2023 and later. Allowable prior-year credits are used before current-year credits where the ordering rules apply; credit ordering follows Form CT-1120K.

Source: 2025 Form CT-1120 RDC — Research and Development Expenditures Tax Credit (§12-217n) (official external site, opens in a new tab) · Conn. Gen. Stat. §12-217zz — Limitation on credits (official external site, opens in a new tab) · Research and Development Expenses Tax Credit (Corporation Credit Guide) (official external site, opens in a new tab) · 2025 Form CT-1120K — Business Tax Credit Summary (official external site, opens in a new tab)

Carryforward

15 income years
  • §12-217n credits earned in income years beginning on or after January 1, 2021: up to 15 income years. Older credits have different historical treatment.
  • §12-217j credits: 15 income years.
  • No carryback.

Connecticut carryforward rules are tax-year dependent. The calculator models current rules for supported tax years and does not overwrite historical treatment.

Source: Research and Development Expenses Tax Credit (Corporation Credit Guide) (official external site, opens in a new tab) · Conn. Gen. Stat. §12-217j — Research and experimental expenditures credit (official external site, opens in a new tab)

Connecticut R&D Credit Exchange / Refund

§12-217ee — special exchangeCT-1120 XCH
  • Qualified small business for the exchange: previous-year gross income not over $70 million, not met through related persons.
  • Must be unable to use the credit because it has no Corporation Business Tax liability (the minimum tax and capital base tax are not treated as liability); it may instead carry the credit forward.
  • Only credits earned in the current year may be exchanged.
  • Exchange value: 65% of the credit; 90% for qualifying biotechnology companies for income years beginning on or after January 1, 2025.
  • Maximum $1,500,000 per income year. Applied for on Form CT-1120 XCH.

Source: Conn. Gen. Stat. §12-217ee — Exchange of R&D and R&E credits by qualified small businesses (official external site, opens in a new tab) · 2025 Form CT-1120 XCH — Application for Exchange of R&D or R&E Tax Credits by a Qualified Small Business (official external site, opens in a new tab) · 2025 Developments — Corporation Business Tax Credits (official external site, opens in a new tab)

Research Must Be Conducted in Connecticut

Research location

Qualifying expenditures must relate to research and experimental activities conducted in Connecticut. Having a Connecticut office does not make research performed elsewhere eligible.

Source: Conn. Gen. Stat. §12-217j — Research and experimental expenditures credit (official external site, opens in a new tab) · Conn. Gen. Stat. §12-217n — Research and development expenses credit (official external site, opens in a new tab)

Recent Connecticut Changes

2025 / 2026
Recent changes
YearChangeStatus
2025Expanded "taxpayer" definitions for §§12-217n and 12-217j (income years beginning on or after January 1, 2025)Enacted
2025Biotechnology exchange value increased from 65% to 90% (income years beginning on or after January 1, 2025)Enacted
2026Separate 2026 pass-through R&D credit (personal income tax; HB 7008, 2025 session)Rule implementation under review — enactment not confirmed; not modeled

Connecticut expanded eligibility for certain entities beginning in 2025. Entity-specific eligibility should be reviewed against the current statutory definitions. Pass-through and individual income tax R&D incentives are kept separate from the corporate §12-217n calculation.

Source: 2025 Developments — Corporation Business Tax Credits (official external site, opens in a new tab) · Public Act 25-165 (Substitute House Bill 7166) (official external site, opens in a new tab) · HB 7008 (2025) — R&D expenses tax credit for pass-through entities (bill status) (official external site, opens in a new tab)

Connecticut Definitions vs Federal §174

Connecticut uses its own statutory definitions for research and development expenses. Do not assume the federal post-2021 §174 amortization treatment automatically determines the Connecticut R&D credit base — §12-217n refers to §174 as in effect on May 28, 1993. For §12-217j, use the current Connecticut statutory and form definitions.

Source: Conn. Gen. Stat. §12-217n — Research and development expenses credit (official external site, opens in a new tab) · Conn. Gen. Stat. §12-217j — Research and experimental expenditures credit (official external site, opens in a new tab)

Official Forms

Tax-Year Matrix

Connecticut calculator support by tax year
Tax year§12-217n§12-217jCalculator
2024SupportedSupportedYes
2025SupportedSupportedYes (90% biotech exchange)
2026SupportedSupportedYes

Core calculation supported; advanced eligibility/limitation may require review (workforce reductions above $200 million, combined groups, entity-specific eligibility, credit ordering on CT-1120K).

Source: 2025 Form CT-1120 RDC — Research and Development Expenditures Tax Credit (§12-217n) (official external site, opens in a new tab) · 2025 Form CT-1120RC — Research and Experimental Expenditures Tax Credit (§12-217j) (official external site, opens in a new tab)

Tax-Year Timeline

Each entry applies to the tax years shown. Rules are kept when the law changes, so earlier years remain visible.

  1. Tax years: 2025 and laterActive

    2025 and later

    §12-217n and §12-217j as above; expanded taxpayer definitions; 90% biotechnology exchange value.

    • Separate 2026 pass-through R&D credit: rule implementation under review (enactment not confirmed).
  2. Tax years: 2023–2024Historical

    2023–2024

    §12-217n and §12-217j; R&D/R&E credits up to 70% of tax; 65% exchange value.

    • 2022: R&D/R&E credits up to 60% of tax.

Federal R&D Credit vs Connecticut R&D Credits

Research performed in Connecticut may still qualify for the federal R&D tax credit under IRC §41 if the taxpayer and the research activities satisfy the federal requirements, including the four-part test and the rules for qualified research expenses.

Federal: IRC §41. Connecticut: §12-217n and §12-217j. They are separate programs with their own rules — evaluate them independently. The Connecticut credits are not a percentage of the federal credit, and federal qualification does not establish Connecticut eligibility.

Calculator Verified

Connecticut R&D Tax Credit Calculator

Verified for tax years 2024–2026. Results are estimates that show every intermediate value.

Open the Connecticut R&D Tax Credit Calculator

Connecticut R&D Credit FAQs

Does Connecticut have an R&D tax credit?

Yes. Connecticut has separate R&D expenses (§12-217n) and R&E incremental (§12-217j) tax credits.

What is the Connecticut R&D tax credit rate?

It depends on the program and taxpayer. §12-217n uses a statutory rate schedule, including 6% for qualified small businesses. §12-217j provides a 20% credit on the incremental increase in qualifying Connecticut R&E expenditures.

Can Connecticut businesses claim both credits?

Potentially, subject to the statutory interaction rules. The §12-217j incremental increase reduces the R&D expense amount used for §12-217n.

What is the Connecticut small-business R&D credit?

A qualified small business under §12-217n (previous-year gross income not over $100 million) generally receives a 6% tentative credit on qualifying R&D expenses, subject to limitations.

What is the Connecticut incremental R&E credit?

20% of the increase in qualifying Connecticut R&E expenditures over the preceding income year.

How long can Connecticut R&D credits be carried forward?

Current credits generally have a 15-year carryforward, with historical exceptions for older §12-217n credits. There is no carryback.

Can Connecticut R&D credits be refunded?

Certain qualifying small businesses with no applicable Connecticut tax liability may be eligible to exchange qualifying current-year credits for a refund, subject to statutory requirements.

What is the Connecticut biotechnology refund percentage?

For applicable income years beginning on or after January 1, 2025, qualifying biotechnology companies may receive a 90% exchange/refund value rather than the general 65% rate, subject to the requirements.

Does Connecticut follow federal Section 174?

The Connecticut credit statutes use specific statutory definitions. Federal §174 treatment should not automatically be substituted for Connecticut's statutory credit base.

Where are Connecticut R&D credits reported?

On Forms CT-1120 RDC and CT-1120RC, with CT-1120K as applicable; exchanges use CT-1120 XCH.

Official Connecticut Sources

Research Methodology & Provenance

Verification
Verified against official sources
Rules last verified
October 3, 2026
Last reviewed
October 3, 2026
Tax years covered
2024, 2025, 2026
Primary authority
Connecticut Department of Revenue Services (official external site, opens in a new tab)
Other authorities
Connecticut General Assembly
Key authorities
  • Conn. Gen. Stat. §12-217n
  • §12-217j
  • §12-217ee
  • §12-217zz
  • CT-1120 RDC
  • CT-1120RC
  • CT-1120 XCH
  • CT-1120K
Research approach
Conn. Gen. Stat. Chapter 208, 2025 DRS forms and corporation credit guides, DRS 2025 developments and Public Act 25-165. Each source was located on an official Connecticut government domain and its cited content confirmed. Connecticut R&D tax-credit rules are tax-year dependent; this page and calculator distinguish the §12-217n R&D expenses credit from the §12-217j incremental R&E credit and model the supported tax years separately.

Verified for income years 2024–2026 against Conn. Gen. Stat. §§12-217n, 12-217j, 12-217ee and 12-217zz, 2025 Forms CT-1120 RDC, CT-1120RC, CT-1120 XCH and CT-1120K, DRS credit guides and 2025 developments, and Public Act 25-165. A 2026 pass-through R&D credit bill (HB 7008, 2025) was reviewed; its enactment was not confirmed and it is not modeled.

How research is conducted: methodology · state research coverage.

ResearchTaxCredits.org provides research and estimation tools for informational purposes only. Calculator results are estimates based on the inputs provided and the rules modeled for the selected tax year. They are not a determination of eligibility, tax advice, or a substitute for the official Connecticut forms, instructions, statutes, or professional tax advice.

Disclaimer: ResearchTaxCredits.org is an independent research and educational website. It is not affiliated with or endorsed by the IRS, U.S. Treasury, or any state tax authority. Tax laws, regulations, forms, deadlines, and administrative guidance can change. Calculator results are estimates for informational purposes and should not be treated as tax advice or as a determination that a taxpayer qualifies for a credit. This page is general research about Connecticut tax law; it is not affiliated with or endorsed by Connecticut Department of Revenue Services. Full disclaimer.